abstract |
The present invention relates to a composition for preventing, ie, inhibiting infection, or treating prion diseases containing aspirin as an active ingredient, and aspirin can effectively inhibit the production and aggregation of PrP Sc , an abnormal prion protein, by increasing the activity of plasmin. Therefore, it can be usefully used for suppressing and treating infections of prion diseases. |